Study of phenolic compounds in the Feverfew Herb by TLC and HPLC methods




feverfew, herb, Aster family, thin layer chromatography, high performance liquid chromatography, flavonoids, hydroxycinnamic acids


Topicality. The search of new plant sources of biologically active substances is an actual issue for the pharmaceutical science. The feverfew (Tanacetum parthenium (L.) Schultz Bip) is one of the prospective species of the Aster family. Its chemical composition mainly consists of phenolic compounds and sesquiterpene lactones. According to the latest data of the foreign sources feverfew herb phenolic compounds stipulate a prominent anti-inflammatory effect. This species is successfully used to treat the chronic inflammatory diseases of the connective tissue. Therefore, the determination of the qualitative composition and quantitative content in the samples of domestic feverfew raw material is actual.
Aim. To determinate the qualitative composition and quantitative content of phenolic compounds in the feverfew herb.
Materials and methods. The object was the feverfew herb collected in July 2017 on the territory of the Botanical garden of the National University of Pharmacy. The qualitative composition and quantitative content were determinated by the thin layer chromatography (TLC) and high performance liquid chromatography (HPLC) methods.
Results and discussion. Chlorogenic and cichoric acids zones, luteolin and luteolin7-glucoside in comparison with
their zones of reference standards were identified by TLC method. 12 compounds were identified and determinated by HPLC method. Hydroxycinnamic acids, namely 3,5-dicaffeoylquinic acid (1.575 %), 4,5-dicaffeoylquinic acid (1.308 %) and chlorogenic acid (0.784 %) were accumulated in the feverfew herb in the greatest amount. Among flavonoids, apigenin-7-glucoside (0.071 %) and kaempferol (0.041 %) prevailed.
Conclusions. For the first time the qualitative composition and quantitative content in the feverfew herb were determinated by TLC and HPLC methods. The high content of the phenolic compounds in the plant raw material attests to the opportunity of feverfew herb standardization by such classes as hydroxycinnamic acids and flavonoids. The data obtained attest to the perspective creating a medicine with the high anti inflammatory activity based on the feverfew herb.

Author Biographies

K. R. Hordiei, National University of Pharmacy

postgraduate student of the Department of Botany

T. M. Gontova, National University of Pharmacy

Doctor of Pharmacy, Professor, head of the Department of Botany

A. G. Serbin, National University of Pharmacy

Doctor of Pharmacy, Professor of the Department of Botany

A. G. Kotov, Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines.

Doctor of Pharmacy, head of the Department of the State Pharmacopoeia of Ukraine

E. E. Kotova, Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines

PhD in Pharmacy, head of the sector “Experimental support for the development plant raw material”


Williams, C. A., Harborne, J. B., Geiger, H., Hoult, J. R. (1999). The flavonoids of Tanacetum parthenium and T. vulgare and their anti–inflammatory properties. Phytochemistry, 51, 417–423.

Long, C., Sauleau, P., David, B., Lavaud, C., Cassabois, V., Ausseil, F., & Massiot, G. (2003). Bioactive flavonoids of Tanacetum parthenium revisited. Phytochemistry, 64 (2), 567–569.

Pareek, A., Suthar, M., Rathore, G., & Bansal, V. (2011). Feverfew (Tanacetum parthenium L.) : A systematic review. Pharmacognosy Reviews, 5 (9),

Rezaei, F., Jamei, R., & Heidari, R. (2017). Evaluation of the Phytochemical and Antioxidant Potential of Aerial Parts of Iranian Tanacetum parthenium. Pharmaceutical Sciences, 23 (2), 136–142.

Williams, C. A., Hoult, J. R. S., Harborne, J. B., Greenham, J., & Eagles, J. (1995). A biologically active lipophilic flavonol from Tanacetum parthenium. Phytochemistry, 38 (1), 267–270.

Shynkovenko, I. L., Ilyina, T. V., Goryacha, O. V., Kovalyova, A. M., Komissarenko, A. М., Shemchuk, N. S., & Golembiovska, O. I. (2018). Phenolic compounds of the liquid extract from cleavers herb (galium aparine l.). Vìsnik Farmacìï, 3 (95), 19–24.

Derzhavna Farmakopeia Ukrainy : v 3 t. (2015). Derzhavne pidpryiemstvo “Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv”. Kharkiv : Derzhavne pidpryiemstvo “Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv”, 3, 732.

Santos, F. M., Malafaia, C. A., Simas, D. L. R., Paulino, A. B., Muzitano, M. F., Simas, N. K., … Leal, I. C. R. (2019). Phenolic compounds from Tocoyena bullata mart (Rubiaceae) with inhibitory activity in mast cells degranulation. Natural Product Research, 1–4.

Naveed, M., Hejazi, V., Abbas, M., Kamboh, A. A., Khan, G. J., Shumzaid, M., XiaoHui, Z. (2018). Chlorogenic acid (CGA): A pharmacological review

and call for further research. Biomedicine & Pharmacotherapy, 97, 67–74.

Nabavi, S. F., Braidy, N., Gortzi, O., Sobarzo– Sanchez, E., Daglia, M., Skalicka–Woźniak, K., & Nabavi, S. M. (2015). Luteolin as an anti-inflammatory and neuroprotective agent : A brief review. Brain Research Bulletin, 119, 1–11.

Wu, G., Li, J., Yue, J., Zhang, S., & Yunusi, K. (2017). Liposome encapsulated luteolin showed enhanced antitumor efficacy to colorectal carcinoma. Molecular Medicine Reports, 17 (2), 2456–2464

Palombo, R., Savini, I., Avigliano, L., Madonna, S., Cavani, A., Albanesi, C., … Terrinoni, A. (2016). Luteolin–7–glucoside inhibits IL–22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model. Cell Death & Disease, 7 (8), 2344–2344.

Song, Y. S., & Park, C. M. (2014). Luteolin and luteolin–7–O-glucoside strengthen antioxidative potential through the modulation of Nrf2/MAPK mediated HO–1 signaling cascade in RAW 264.7 cells. Food and Chemical Toxicology, 65, 70–75.





Pharmaceutical chemistry and pharmacognosy